Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank100
3Y CAGR+74.6%
5Y CAGR+14.5%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+74.6%/yr
Annual compound
5Y CAGR
+14.5%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
2x
Strong expansion
Streak
3 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 9.96 | +7.4% |
| 2024 | 9.27 | +207.0% |
| 2023 | 3.02 | +61.4% |
| 2022 | 1.87 | -32.5% |
| 2021 | 2.77 | -45.2% |
| 2020 | 5.06 | +107.6% |
| 2019 | -66.86 | -2.7% |
| 2018 | -65.13 | - |